Study Stopped
Study was terminated prior to full enrollment
Effect of Lost Wage Reimbursement to Kidney Donors on Living Donation Rates
Randomized Controlled Trial to Evaluate the Effect of Lost Wage Reimbursement to Potential Kidney Donors On Living Donation Rates
1 other identifier
interventional
1,310
1 country
6
Brief Summary
The study is designed as a randomized controlled trial. The investigators hypothesize that kidney transplant recipient candidates whose donors are offered reimbursement of lost wages (treatment arm) will have a higher probability of receiving a living donor kidney transplant than those randomized to no offer of lost wage reimbursement (control arm). The study expects to demonstrate incremental living donor kidney transplants by assisting individuals who wish to be living organ donors but would be otherwise unable to do so due to the obligatory forfeit of income during the evaluation, donation surgery, and post-operative recuperation periods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2017
Typical duration for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2017
CompletedStudy Start
First participant enrolled
November 15, 2017
CompletedFirst Posted
Study publicly available on registry
November 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 17, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 20, 2020
CompletedJanuary 3, 2022
January 1, 2020
2.6 years
November 14, 2017
December 13, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effect of offering wage reimbursement on rate of living donor kidney transplant
Number of kidney transplant recipient candidates in intervention vs. control group who receive a living door transplant within one year of their first visit to the participating transplant center for evaluation as a potential kidney transplant recipient (time zero)
One year from time zero
Secondary Outcomes (2)
Difference in time to outcome events (living donor transplant, deceased donor transplant, removal from transplant waiting list, death) between control group and intervention arm
Time zero to one year
Effect of offering donor wage reimbursement on demographic characteristics of living kidney donor pool
Time zero to one year
Study Arms (2)
Intervention
EXPERIMENTALKidney transplant recipient candidates who are informed that their living donor candidates can receive reimbursement for lost wages incurred during the evaluation, donation surgery and recuperation
Control
NO INTERVENTIONKidney transplant recipient candidates who receive standard of care (donors are not offered wage reimbursement)
Interventions
Kidney transplant recipients are informed that their donors may be eligible for lost wage reimbursement
Eligibility Criteria
You may qualify if:
- Age ≥18 at enrollment
- Meet participating transplant center standards to initiate an evaluation to receive a kidney transplant
- Kidney-only or kidney intended to be followed by other organ (e.g. deceased donor pancreas)
- First-time recipient candidate
- Capable of providing informed consent
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Arbor Research Collaborative for Healthlead
- Laura and John Arnold Foundationcollaborator
- American Society of Transplant Surgeonscollaborator
Study Sites (6)
UCLA Kidney and Pancreas Transplant Program in collaboration with the Transplant Research and Education Center (TREC)
Los Angeles, California, 90024, United States
University of Colorado
Denver, Colorado, 80045, United States
Michigan Medicine - University of Michigan
Ann Arbor, Michigan, 48109, United States
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Mt. Sinai Medical Center
New York, New York, 10029, United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Related Publications (23)
Agerskov H, Ludvigsen MS, Bistrup C, Pedersen BD. From donation to everyday life: Living kidney donors' experiences three months after donation. J Ren Care. 2016 Mar;42(1):43-52. doi: 10.1111/jorc.12137. Epub 2015 Oct 14.
PMID: 26463844BACKGROUNDLarson DB, Jacobs C, Berglund D, Wiseman J, Garvey C, Gillingham K, Ibrahim HN, Matas AJ. Return to normal activities and work after living donor laparoscopic nephrectomy. Clin Transplant. 2017 Jan;31(1). doi: 10.1111/ctr.12862. Epub 2016 Dec 22.
PMID: 27740731BACKGROUNDClarke KS, Klarenbach S, Vlaicu S, Yang RC, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network. The direct and indirect economic costs incurred by living kidney donors-a systematic review. Nephrol Dial Transplant. 2006 Jul;21(7):1952-60. doi: 10.1093/ndt/gfl069. Epub 2006 Mar 22.
PMID: 16554329BACKGROUNDWaterman AD, Covelli T, Caisley L, Zerega W, Schnitzler M, Adams D, Hong BA. Potential living kidney donors' health education use and comfort with donation. Prog Transplant. 2004 Sep;14(3):233-40. doi: 10.1177/152692480401400309.
PMID: 15495783BACKGROUNDWarren PH, Gifford KA, Hong BA, Merion RM, Ojo AO. Development of the National Living Donor Assistance Center: reducing financial disincentives to living organ donation. Prog Transplant. 2014 Mar;24(1):76-81. doi: 10.7182/pit2014593.
PMID: 24598569BACKGROUNDRodrigue JR, Schold JD, Morrissey P, Whiting J, Vella J, Kayler LK, Katz D, Jones J, Kaplan B, Fleishman A, Pavlakis M, Mandelbrot DA; KDOC Study Group. Direct and Indirect Costs Following Living Kidney Donation: Findings From the KDOC Study. Am J Transplant. 2016 Mar;16(3):869-76. doi: 10.1111/ajt.13591. Epub 2016 Feb 4.
PMID: 26845630BACKGROUNDRodrigue JR, Schold JD, Morrissey P, Whiting J, Vella J, Kayler LK, Katz D, Jones J, Kaplan B, Fleishman A, Pavlakis M, Mandelbrot DA; KDOC Study Group. Predonation Direct and Indirect Costs Incurred by Adults Who Donated a Kidney: Findings From the KDOC Study. Am J Transplant. 2015 Sep;15(9):2387-93. doi: 10.1111/ajt.13286. Epub 2015 May 5.
PMID: 25943721BACKGROUNDRodrigue JR, Schold JD, Mandelbrot DA. The decline in living kidney donation in the United States: random variation or cause for concern? Transplantation. 2013 Nov 15;96(9):767-73. doi: 10.1097/TP.0b013e318298fa61.
PMID: 23759882BACKGROUNDManyalich M, Ricart A, Martinez I, Balleste C, Paredes D, Vilardell J, Avsec D, Dias L, Fehrman-Eckholm I, Hiesse C, Kyriakides G, Line PD, Maxwell A, Nanni Costa A, Paez G, Turcu R, Walaszewski J. EULID project: European living donation and public health. Transplant Proc. 2009 Jul-Aug;41(6):2021-4. doi: 10.1016/j.transproceed.2009.05.021.
PMID: 19715823BACKGROUNDPruett TL, Tibell A, Alabdulkareem A, Bhandari M, Cronin DC, Dew MA, Dib-Kuri A, Gutmann T, Matas A, McMurdo L, Rahmel A, Rizvi SA, Wright L, Delmonico FL. The ethics statement of the Vancouver Forum on the live lung, liver, pancreas, and intestine donor. Transplantation. 2006 May 27;81(10):1386-7. doi: 10.1097/01.tp.0000214976.36526.e3. No abstract available.
PMID: 16732173BACKGROUNDCollier R. Ontario and Manitoba to reimburse expenses for living organ donors. CMAJ. 2008 Jun 3;178(12):1535. doi: 10.1503/cmaj.080704. No abstract available.
PMID: 18519896BACKGROUNDConcejero AM, Chen CL. Ethical perspectives on living donor organ transplantation in Asia. Liver Transpl. 2009 Dec;15(12):1658-61. doi: 10.1002/lt.21930.
PMID: 19938130BACKGROUNDHippen B, Matas A. Incentives for organ donation in the United States: feasible alternative or forthcoming apocalypse? Curr Opin Organ Transplant. 2009 Apr;14(2):140-6. doi: 10.1097/MOT.0b013e3283295e0d.
PMID: 19307965BACKGROUNDHowell E, Corder L, Dobson A. Out-of-pocket health expenses for Medicaid and other poor and near-poor persons in 1980. Natl Med Care Util Expend Surv B. 1985 Aug;(4):1-52.
PMID: 10313450BACKGROUNDJotkowitz A. Notes on the new Israeli organ donation law-2008. Transplant Proc. 2008 Dec;40(10):3297-8. doi: 10.1016/j.transproceed.2008.08.128.
PMID: 19100375BACKGROUNDPrice D. Living kidney donation in Europe: legal and ethical perspectives--the EUROTOLD Project. Transpl Int. 1994;7 Suppl 1:S665-7. doi: 10.1111/j.1432-2277.1994.tb01468.x.
PMID: 11271334BACKGROUNDRithalia A, McDaid C, Suekarran S, Norman G, Myers L, Sowden A. A systematic review of presumed consent systems for deceased organ donation. Health Technol Assess. 2009 May;13(26):iii, ix-xi, 1-95. doi: 10.3310/hta13260.
PMID: 19422754BACKGROUNDRizvi AH, Naqvi AS, Zafar NM, Ahmed E. Regulated compensated donation in Pakistan and Iran. Curr Opin Organ Transplant. 2009 Apr;14(2):124-8. doi: 10.1097/mot.0b013e328326f6ef.
PMID: 19469028BACKGROUNDRodrigue JR, Crist K, Roberts JP, Freeman RB Jr, Merion RM, Reed AI. Stimulus for organ donation: a survey of the American Society of Transplant Surgeons membership. Am J Transplant. 2009 Sep;9(9):2172-6. doi: 10.1111/j.1600-6143.2009.02741.x. Epub 2009 Jul 16.
PMID: 19624568BACKGROUNDVlaicu S, Klarenbach S, Yang RC, Dempster T, Garg AX. Current Canadian initiatives to reimburse live organ donors for their non-medical expenses. Can J Public Health. 2007 Nov-Dec;98(6):481-3. doi: 10.1007/BF03405443.
PMID: 19039887BACKGROUNDSells R. Incentives for organ donation: some ethical issues. Ann Transplant. 2004;9(1):23-4.
PMID: 15478883BACKGROUNDSchulz-Baldes A, Delmonico FL. Improving institutional fairness to live kidney donors: donor needs must be addressed by safeguarding donation risks and compensating donation costs. Transpl Int. 2007 Nov;20(11):940-6. doi: 10.1111/j.1432-2277.2007.00542.x. Epub 2007 Aug 17.
PMID: 17711405BACKGROUNDWolters HH, Heidenreich S, Senninger N. Living donor kidney transplantation: chance for the recipient--financial risk for the donor? Transplant Proc. 2003 Sep;35(6):2091-2. doi: 10.1016/s0041-1345(03)00675-4.
PMID: 14529850BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kimberly A. Gifford, MBA
American Society of Transplant Surgeons
- PRINCIPAL INVESTIGATOR
Judd Kessler, PhD
Wharton School, University of Pennsylvania
- PRINCIPAL INVESTIGATOR
Robert M. Merion, MD, FACS
Arbor Research Collaborative for Health
- PRINCIPAL INVESTIGATOR
Amit K. Mathur, MD
Mayo Clinic
- PRINCIPAL INVESTIGATOR
Akinlolu O. Ojo, MD, PhD, MBA
University of Arizona Health Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2017
First Posted
November 22, 2017
Study Start
November 15, 2017
Primary Completion
June 17, 2020
Study Completion
October 20, 2020
Last Updated
January 3, 2022
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share
The study was terminated prior to full enrollment so there are no data to be shared